FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2313711049> ?p ?o ?g. }

• W2313711049 endingPage "54" @default.
• W2313711049 startingPage "54.1" @default.
• W2313711049 abstract "<h3></h3> A major unmet need in the field of spondyloarthritis (SpA) is the lack of feasible and sufficiently responsive tools to measure objective features of inflammation and disease progression. A major development in the field has been highly discriminatory MRI-based scoring tools that can quantify the degree of bone marrow edema (BME) in the sacroiliac joints (SIJ) and spine. Formal methods for quantifying disease activity in the SIJ can be generally categorized as being primarily based on either a global scheme that focuses on the single most severely affected semi-coronal image or on a more detailed method that scores several consecutive semicoronal images that depict the synovial portion of the SIJ (SPARCC SIJ score). The presence and extent of BME in the cartilaginous portion of the joint is the primary MRI feature that is scored. In the SPARCC method, each SIJ is divided into quadrants and the presence of BME in each quadrant is scored on a dichotomous basis with additional weighting for intensity and depth. ASAS/OMERACT conducted a multi-reader exercise evaluating the different scoring methods for reliability and sensitivity to change. Agreement between readers and sensitivity to change was somewhat better for the more detailed SPARCC scoring method. This approach to scoring inflammation in the SIJ is to date the only method shown to discriminate between treatment groups in a randomized placebo-controlled trial. Systematic evaluation of the SIJ and the use of an online training module (www.arthritisdoctor.ca) have been shown to enhance reliability. Several methods have recently been described for scoring structural lesions in the SIJ. The SPARCCC SIJ structural lesion score (SSS) has recently been shown to discriminate between therapies and show that anti-TNF reduces erosions. Two primary approaches have been validated for the quantification of the extent of inflammation in the spine for the purposes of evaluation of new therapeutics in clinical trials. The first method, the ASspiMRI-a (AS spinal MRI activity) index, scores the severity of BME and erosions at each DVU according to a 0 to 6 scoring scheme with higher values being assigned to the presence of erosions. The score for BME is based on the total area involved in the DVU according to a <25%, 25-50%, and >50% grading scheme. The Berlin method does not score erosions but otherwise is the same as ASspiMRI-a. For both methods all 23 DVUs in the spine are scored in a single sagittal plane. This approach has been shown to be reproducible and to discriminate between treatment groups in trials of anti-TNF therapies. The second method, the SPARCC MRI spinal inflammation index, takes advantage of the ability of MRI to visualize lesions in three dimensions and scores a maximum of 6 of the most severely affected DVU for the purposes of clinical trials. Since inflammatory lesions observed on MRI are often asymmetrical there are theoretical advantages to using a scoring method that systematically assesses lesions in several dimensions. The rationale for the choice of 6 affected DVU is based on data that shows that the mean number of affected DVU in patients with AS is 3.2. However, this method has also been validated for scoring all 23 DVU where discrimination appears comparable to a more limited assessment of 6DVU. In the SPARCC method each DVU is divided into quadrants with bone edema in each quadrant being scored on a dichotomous basis as being present or absent with additional weighting for intensity and depth. Lesions in each affected DVU are scored in 3 consecutive sagittal slices so that the extent of the lesion can be defined in both the coronal and the sagittal planes and also in the lateral segments of the spine, which may be important for assessing inflammation in the thoracic spine. Recent work has shown that a major portion of spinal inflammation in the thoracic spine occurs in the lateral segments involving the costovertebral and costotransverse joints. A validation exercise has been conducted by ASAS/OMERACT using multiple readers to determine which method performs best with respect to feasibility and ability to discriminate between active and control therapies. Both scoring methods demonstrated high responsiveness after administration of anti-TNFα therapies although the SPARCC method was consistently more reproducible, particularly when evaluated by neutral observers with limited experience in either method. A recent report has described a scoring method for assessing fat lesions in the spine, the Fat SpA Spine score (FASSS), which reliably detects change in fat lesion score. Further study in clinical trials is now warranted for further validation of MRI-based structural lesion scores in both the spine and SIJ. <h3>Disclosure of Interest</h3> None declared <h3>DOI</h3> 10.1136/annrheumdis-2014-eular.6221" @default.
• W2313711049 created "2016-06-24" @default.
• W2313711049 creator A5042741739 @default.
• W2313711049 date "2014-06-01" @default.
• W2313711049 modified "2023-09-27" @default.
• W2313711049 title "SP0210 Advanced Imaging in Clinical Trials for Spondyloarthritis" @default.
• W2313711049 doi "https://doi.org/10.1136/annrheumdis-2014-eular.6221" @default.
• W2313711049 hasPublicationYear "2014" @default.
• W2313711049 type Work @default.
• W2313711049 sameAs 2313711049 @default.
• W2313711049 citedByCount "0" @default.
• W2313711049 crossrefType "journal-article" @default.
• W2313711049 hasAuthorship W2313711049A5042741739 @default.
• W2313711049 hasConcept C121332964 @default.
• W2313711049 hasConcept C126838900 @default.
• W2313711049 hasConcept C13483470 @default.
• W2313711049 hasConcept C143409427 @default.
• W2313711049 hasConcept C163258240 @default.
• W2313711049 hasConcept C183115368 @default.
• W2313711049 hasConcept C1862650 @default.
• W2313711049 hasConcept C2776213234 @default.
• W2313711049 hasConcept C2778579456 @default.
• W2313711049 hasConcept C2778614933 @default.
• W2313711049 hasConcept C43214815 @default.
• W2313711049 hasConcept C62520636 @default.
• W2313711049 hasConcept C71924100 @default.
• W2313711049 hasConceptScore W2313711049C121332964 @default.
• W2313711049 hasConceptScore W2313711049C126838900 @default.
• W2313711049 hasConceptScore W2313711049C13483470 @default.
• W2313711049 hasConceptScore W2313711049C143409427 @default.
• W2313711049 hasConceptScore W2313711049C163258240 @default.
• W2313711049 hasConceptScore W2313711049C183115368 @default.
• W2313711049 hasConceptScore W2313711049C1862650 @default.
• W2313711049 hasConceptScore W2313711049C2776213234 @default.
• W2313711049 hasConceptScore W2313711049C2778579456 @default.
• W2313711049 hasConceptScore W2313711049C2778614933 @default.
• W2313711049 hasConceptScore W2313711049C43214815 @default.
• W2313711049 hasConceptScore W2313711049C62520636 @default.
• W2313711049 hasConceptScore W2313711049C71924100 @default.
• W2313711049 hasIssue "Suppl 2" @default.
• W2313711049 hasLocation W23137110491 @default.
• W2313711049 hasOpenAccess W2313711049 @default.
• W2313711049 hasPrimaryLocation W23137110491 @default.
• W2313711049 hasRelatedWork W1841185769 @default.
• W2313711049 hasRelatedWork W2168927295 @default.
• W2313711049 hasRelatedWork W2262423180 @default.
• W2313711049 hasRelatedWork W2377341204 @default.
• W2313711049 hasRelatedWork W3034871388 @default.
• W2313711049 hasRelatedWork W3085360753 @default.
• W2313711049 hasRelatedWork W3125793085 @default.
• W2313711049 hasRelatedWork W4226217766 @default.
• W2313711049 hasRelatedWork W4298316838 @default.
• W2313711049 hasRelatedWork W4225155521 @default.
• W2313711049 hasVolume "73" @default.
• W2313711049 isParatext "false" @default.
• W2313711049 isRetracted "false" @default.
• W2313711049 magId "2313711049" @default.
• W2313711049 workType "article" @default.